HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $922,000 | +172.0% | 1,387,665 | +579.6% | 0.01% | +225.0% |
| Q2 2019 | $339,000 | -72.3% | 204,189 | -58.3% | 0.00% | -75.0% |
| Q1 2019 | $1,224,000 | -1.3% | 489,475 | +0.3% | 0.02% | -11.1% |
| Q4 2018 | $1,240,000 | +26.8% | 488,000 | +62.7% | 0.02% | +100.0% |
| Q2 2018 | $978,000 | +150.1% | 300,000 | +234.4% | 0.01% | +125.0% |
| Q4 2015 | $391,000 | -55.1% | 89,722 | -21.4% | 0.00% | -60.0% |
| Q3 2015 | $870,000 | -62.4% | 114,113 | -45.0% | 0.01% | -23.1% |
| Q2 2015 | $2,312,000 | – | 207,338 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 5,790,269 | $3,848,000 | 3.74% |
| PERKINS CAPITAL MANAGEMENT INC | 2,353,153 | $1,564,000 | 1.35% |
| Diametric Capital, LP | 269,822 | $179,000 | 0.15% |
| Nantahala Capital Management | 5,000,000 | $3,323,000 | 0.12% |
| Sio Capital Management, LLC | 300,000 | $199,000 | 0.06% |
| Cowen Prime Services LLC | 100,000 | $66,000 | 0.03% |
| Fondren Management LP | 40,375 | $27,000 | 0.02% |
| Kalos Management, Inc. | 66,900 | $46,000 | 0.02% |
| Alyeska Investment Group, L.P. | 1,387,665 | $922,000 | 0.01% |
| Hayden Royal, LLC | 12,000 | $8,000 | 0.01% |